FDAnews
www.fdanews.com/articles/125518-vote-of-confidence-for-gene-therapy-35-million-for-genetix-pharmaceuticals

Vote of Confidence for Gene Therapy: $35 Million for Genetix Pharmaceuticals

March 22, 2010
Genetix Pharmaceuticals, Inc., one of the leading companies in gene therapy, has secured $35 million in series B funding from investors Third Rock Ventures and Genezyme Joint Ventures.
BNET